These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16565311)

  • 1. Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta.
    Nishihara M; Miura T; Miki T; Sakamoto J; Tanno M; Kobayashi H; Ikeda Y; Ohori K; Takahashi A; Shimamoto K
    Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H748-55. PubMed ID: 16565311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
    Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
    Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO.
    Sato T; Tanno M; Miki T; Yano T; Sato T; Shimamoto K; Miura T
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):401-8. PubMed ID: 20953685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta.
    Gross ER; Hsu AK; Gross GJ
    Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H827-34. PubMed ID: 16517948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
    Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
    Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
    Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition.
    Miki T; Miura T; Hotta H; Tanno M; Yano T; Sato T; Terashima Y; Takada A; Ishikawa S; Shimamoto K
    Diabetes; 2009 Dec; 58(12):2863-72. PubMed ID: 19755525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt.
    He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y
    Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways.
    Yin Z; Gao H; Wang H; Li L; Di C; Luan R; Tao L
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):756-63. PubMed ID: 19207715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
    Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of phospho-GSK-3β in myocardial protection afforded by activation of the mitochondrial K ATP channel.
    Terashima Y; Sato T; Yano T; Maas O; Itoh T; Miki T; Tanno M; Kuno A; Shimamoto K; Miura T
    J Mol Cell Cardiol; 2010 Nov; 49(5):762-70. PubMed ID: 20692265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection.
    Nishihara M; Miura T; Miki T; Tanno M; Yano T; Naitoh K; Ohori K; Hotta H; Terashima Y; Shimamoto K
    J Mol Cell Cardiol; 2007 Nov; 43(5):564-70. PubMed ID: 17931653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.
    Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B
    Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular hypertrophy abrogates intralipid-induced cardioprotection by alteration of reperfusion injury salvage kinase/glycogen synthase kinase 3β signal.
    Ma LL; Ge HW; Kong FJ; Qian LB; Hu BC; Li Q; Xu L; Liu JQ; Xu YX; Sun RH
    Shock; 2014 May; 41(5):435-42. PubMed ID: 24430545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin-mediated cardioprotection in hearts subjected to ischemia reperfusion.
    Vélez DE; Mestre Cordero VE; Hermann R; de Las Mercedes Fernández Pazos M; Reznik FJ; Sánchez L; Marina Prendes MG
    J Mol Endocrinol; 2023 Oct; 71(3):. PubMed ID: 37924639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xenon preconditioning: the role of prosurvival signaling, mitochondrial permeability transition and bioenergetics in rats.
    Mio Y; Shim YH; Richards E; Bosnjak ZJ; Pagel PS; Bienengraeber M
    Anesth Analg; 2009 Mar; 108(3):858-66. PubMed ID: 19224794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts.
    Gross ER; Hsu AK; Gross GJ
    Circ Res; 2004 Apr; 94(7):960-6. PubMed ID: 14976126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts.
    Hirata A; Minamino T; Asanuma H; Sanada S; Fujita M; Tsukamoto O; Wakeno M; Myoishi M; Okada K; Koyama H; Komamura K; Takashima S; Shinozaki Y; Mori H; Tomoike H; Hori M; Kitakaze M
    Cardiovasc Drugs Ther; 2005 Jan; 19(1):33-40. PubMed ID: 15883754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes abolishes the cardioprotection induced by sevoflurane postconditioning in the rat heart in vivo: roles of glycogen synthase kinase-3β and its upstream pathways.
    Tai W; Shi E; Yan L; Jiang X; Ma H; Ai C
    J Surg Res; 2012 Nov; 178(1):96-104. PubMed ID: 22482760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sevoflurane confers additive cardioprotection to ethanol preconditioning associated with enhanced phosphorylation of glycogen synthase kinase-3β and inhibition of mitochondrial permeability transition pore opening.
    Onishi A; Miyamae M; Inoue H; Kaneda K; Okusa C; Inamura Y; Shiomi M; Koshinuma S; Momota Y; Figueredo VM
    J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):916-24. PubMed ID: 23266287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.